A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation
Clinical trial NCT02869438 · COMPLETED
Trial details
- NCT number
- NCT02869438
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-09
- Primary completion
- 2018-08-01
- Enrollment
- 233
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.